Clinical Trials Browser

Interventional × urelumab × Gastrointestinal × Clear all

NCT02451982 2025-12-03

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT02110082 2017-04-19

Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer

Phase 1 Completed

GastrointestinalHead & Neck

Head and Neck Neoplasms, Colorectal Neoplasms